Zhou, J., Gelot, C., Pantelidou, C., Li, A., Yücel, H., Davis, R. E., . . . D’Andrea, A. D. (2021). A first-in-class Polymerase Theta Inhibitor selectively targets Homologous-Recombination-Deficient Tumors. Nat Cancer.
Παραπομπή Chicago StyleZhou, Jia, et al. "A First-in-class Polymerase Theta Inhibitor Selectively Targets Homologous-Recombination-Deficient Tumors." Nat Cancer 2021.
Παραπομπή MLAZhou, Jia, et al. "A First-in-class Polymerase Theta Inhibitor Selectively Targets Homologous-Recombination-Deficient Tumors." Nat Cancer 2021.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.